HDFC MF and ADIA Lead Rs 777 Crore Block Deal in Corona Remedies

A massive shift in the shareholding pattern of pharmaceutical player Corona Remedies Limited occurred on June 17, 2026, through a significant block deal on the stock exchange. Major institutional players, including HDFC Mutual Fund and the Abu Dhabi Investment Authority (ADIA), emerged as primary buyers in this high-value transaction.

Massive Divestment by Sepia Investments and Anchor Partners

The block deal saw a large-scale exit by two major sellers, totaling approximately Rs 776.9 crore in divestment. Sepia Investments was the primary seller, offloading 43,28,943 shares of Corona Remedies at a price of Rs 1,730 per share, amounting to roughly Rs 748.9 crore.

In addition to Sepia, Anchor Partners participated in the sell-off by divesting 1,61,861 shares at the same execution price of Rs 1,730, contributing another Rs 28 crore to the total deal value. This significant reduction in stake by these entities highlights a major liquidity event for the pharmaceutical company.

HDFC Mutual Fund Dominates the Buy Side

The buying side of the transaction was equally impressive, featuring a diverse group of twelve institutional investors. HDFC Mutual Fund emerged as the heavyweight buyer, single-handedly accounting for more than half of the total deal value. The fund acquired 24,50,000 shares, a move worth approximately Rs 423.9 crore.

Other prominent Indian domestic mutual funds also stepped in to increase their exposure. Aditya Birla Sun Life Mutual Fund purchased 4,90,000 shares worth about Rs 84.8 crore, while Kotak Mahindra Mutual Fund acquired 1,61,861 shares, worth Rs 28 crore—notably matching the exact volume sold by Anchor Partners. Invesco Mutual Fund and WhiteOak Capital Mutual Fund also secured significant positions, with investments of Rs 50 crore and Rs 25.1 crore, respectively.

Global Institutional Interest in Corona Remedies

The deal also signaled strong confidence from international capital, with several global funds picking up stakes in the company. Aberdeen Asian Smaller Companies Investment Trust Plc was a major global participant, buying 4,50,868 shares valued at roughly Rs 78 crore. The Abu Dhabi Investment Authority (ADIA) also participated, acquiring 39,130 shares worth approximately Rs 6.8 crore.

Zu den weiteren beteiligten internationalen Akteuren gehörten der Aberdeen Standard Sicav I - Asian Smaller Companies Fund (47,4 Crore Rs), der India Acorn ICAV - Ashoka WhiteOak Emerging Markets Equity Fund (25,7 Crore Rs) und der TCW White Oak Emerging Markets Equity Fund, der mit dem Erwerb von 1.920 Aktien im Wert von 33 Lakh Rs den kleinsten Anteil erwarb. Diese Mischung aus inländischen Giganten und globalem staatlichem sowie institutionellem Vermögen unterstreicht das wachsende institutionelle Interesse an der Marktposition des Unternehmens.

Kernpunkte